SLC22A6 and central nervous system cancer: Ten genes were positively correlated with DRAXIN, including CDCA8, KIF2C, DLGAP5, KIFA4, CCNB1, MELK, KIF23, GTSE1, ASPM, and GAS2L3, and other ten genes, AKR1C3, RASL10A, SLC25A18, CYP17A1-AS1, ETNPPL, FBXW4, LDHD, SLC22A6, SLC25A48 and MRVI1, were negatively correlated with DRAXIN. Results of co-expressed genes suggest potential molecular functions of DRAXIN in glioma.